• Phone
  • Contact us
  • Locations
  • Search
  • Menu

Share

  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page
.
 
Close this video

Metris Therapeutics: Developing a novel vaginal drug delivery system

PA Consulting Group was asked by Metris Therapeutics, a specialist pharmaceutical company focusing on women’s healthcare, to assist it with establishing a manufacturing process for products to be used in the treatment of benign gynaecological conditions such as menorrhagia/dysmenorrhea, using a novel vaginal drug delivery system. A patent covering the concept of the vaginal delivery system (VDS) was previously filed.

Our initial brief was to turn the concept into a prototype for use in preclinical testing to determine whether the physical characteristics of the product in vitro lent themselves to a safe and effective delivery system.

We also advised on clinical and regulatory aspects of the clinical development programme.

From significant experience of running product development programmes involving multiple suppliers, we recognised the need to establish a formal project team structure comprising function specific workstreams, whose activities would be monitored by a project office and governed by a project steering committee.

This structure and PA’s rapid prototyping ability were major contributory factors to ensuring that the project team met the objectives of taking the concept to phase-one clinical trials within 16 months (including the successful submission of an IND application), and to phase-two trials within 24 months.

Find out more about our work in life sciences.

Contact the life sciences team

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.

×